Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction
University of Arizona
75 participants
Feb 11, 2025
INTERVENTIONAL
Conditions
Summary
All patients will be randomly assigned using a computer randomization algorithm to one of two matched cohort groups. Patients will not be advised which group they belong to until after the completion of the study. One group will be treated with autologous bone graft for bone patellar-tendon bone (BTB) Anterior Cruciate Ligament Reconstruction (ACLR), and the other group will be treated with commercially available DBM (Demineralized bone matrix) putty. Patients will be enrolled from Banner University. Before and after surgery, patient reported outcomes including visual analog pain scale (VAS), Tegner-Lysholm and Cincinnati ACL Test. The principal investigator will evaluate the patients on subjective criteria such as pain and objective criteria including range of motion, arthritic changes seen on radiographs, infection, and ability to kneel.
Eligibility
Inclusion Criteria5
- years old,
- male/female/gender neutral,
- all races not including vulnerable/special consideration populations,
- candidate for anterior cruciate ligament reconstruction with bone patellar bone autograft,
- compliant post operative course.
Exclusion Criteria4
- \< 18, \>41 years of age,
- prior bone patellar bone anterior cruciate ligament reconstruction,
- non-compliance post-operatively,
- nicotine dependence.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
group will be treated with autologous bone graft for BTB ACLR
Demineralized bone matrix (DBM) is a biologic allograft product derived from bone tissue that has undergone a process of demineralization to remove inorganic mineral components while retaining the organic matrix, including proteins and growth factors.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06975306